ICER tries to walk financial tightrope of wider access to obesity meds - FirstWord Pharma

Doubling down on genetics-guided drug development, Regeneron to buy 23andMe – FirstWord Pharma

19 May 2025

Doubling down on genetics-guided drug development, Regeneron to buy 23andMe FirstWord Pharma
23andMe sold out of bankruptcy to Regeneron Financial Times
Bankrupt DNA testing firm 23andMe to be purchased for $256m The Guardian
Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale GlobeNewswire
23andMe Sells Gene-Testing Business to DNA Drug Maker Regeneron Bloomberg